Aster Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.49K Buy
+255
New +$1.95K ﹤0.01% 745
2025
Q2
Sell
-1,047
Closed -$13.3K 1485
2025
Q1
$13.3K Sell
1,047
-7,229
-87% -$89.5K ﹤0.01% 1031
2024
Q4
$100K Buy
8,276
+8,183
+8,799% +$99.4K 0.04% 383
2024
Q3
$1.02K Buy
+93
New +$945 ﹤0.01% 1021

Other funds holding REPL

Aster Capital Management's REPL Position: Q1 2026 in Review

Aster Capital Management opened a new position in Replimune Group (REPL) in Q1 2026: 255 shares worth $2.49K. The stake represents ﹤0.01% of the portfolio and ranks #745 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in REPL as recently as Q1 2025.

Aster Capital Management first reported a position in REPL in Q3 2024 and has held it in 4 quarters since. The position peaked at $100K in Q4 2024. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Aster Capital Management held 255 shares of Replimune Group worth $2.49K as of Q1 2026.
  • Replimune Group was a new Aster Capital Management position in Q1 2026.
  • Replimune Group made up ﹤0.01% of Aster Capital Management's portfolio in Q1 2026, its #745 holding.
  • Aster Capital Management first reported a position in Replimune Group in Q3 2024 and has held it in 4 quarters since.
  • Aster Capital Management's Replimune Group position peaked at $100K in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.